Clinical Trial Update: CKD-828 Primary Hypertension Trial(Dose-selection) [Phase 2]

View source ↗

Summary

Phase 2 dose-selection trial of CKD-828 for hypertension has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• CKD-828

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertension | Phase 2 | Status: COMPLETED